1-13 of 13
Antonio Calles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P5-07-29: Trastuzumab deruxtecan With Pembrolizumab in Previously Treated HER2-Expressing Advanced or Metastatic Breast Cancer: Interim Analyses of the Breast Cohorts from the Open-Label, Multicenter, Phase 1b Study DS8201-A-U106

Free
Hope S. Rugo, Antonio Anton Torres, Hendrik-Tobias Arkenau, Emma Kipps, Antoine Italiano, Antonio Calles Blanco, Georgia Anguera Palacios, Marie Meurer, Jesus Soberino Gracia, Aditya Bardia, Aixa E. Soyano, Anthony Goncalves, Robert Droder, Michael J. Chisamore, Daniel Barrios, Kodai Abe, Dipica Haribhai, Mitchell Rosen, Brandon Cunningham, Florence Dalenc
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): P5-07-29.
https://doi.org/10.1158/1557-3265.SABCS24-P5-07-29
Published: 13 June 2025
View articletitled, Abstract P5-07-29: Trastuzumab deruxtecan With Pembrolizumab in Previously Treated HER2-Expressing Advanced or Metastatic Breast Cancer: Interim Analyses of the Breast Cohorts from the Open-Label, Multicenter, Phase 1b Study DS8201-A-U106
Journal Articles

Abstract S12-04: COVID-19 disease in patients with lung cancer in Spain: GRAVID Lung Cancer Patients Disease (GRAVID study)

Free
Jose Maria Mazarico Gallego, Antonio Calles, Monica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, Ernest Nadal, Rafael Lopez Castro, Ana Lopez-Martin, Edel del Barco, Manuel Domine, Virginia Calvo, Pilar Diz, Carmen Sandoval, Elia Sais Girona, Ivana Gabriela Sullivan, M. Angeles Sala, Gema Garcia Ledo, Jose Ramon Jarabo, Rosa Alvarez Alvarez, Javier Baena, Maria Gonzalez-Cao, Mariano Provencio
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6_Supplement): S12-04.
https://doi.org/10.1158/1557-3265.COVID-19-21-S12-04
Published: 15 March 2021
View articletitled, Abstract S12-04: COVID-19 disease in patients with lung cancer in Spain: GRAVID Lung Cancer Patients Disease (GRAVID study)
Journal Articles

Abstract PO-021: Impact of COVID-19 in continuity of cancer treatment for lung cancer patients

Free
Antonio Calles, Manuel Alva, Inmaculada Aparicio, Javier Soto, Natalia Gutierrez, Marianela Bringas, Vicente Escudero, Roberto Collado, Mar Galera, Rosa Alvarez
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18_Supplement): PO-021.
https://doi.org/10.1158/1557-3265.COVID-19-PO-021
Published: 15 September 2020
View articletitled, Abstract PO-021: Impact of COVID-19 in continuity of cancer treatment for lung cancer patients
Journal Articles

Abstract PO-031: Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid

Free
Antonio Calles, Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, Javier Soto, Mar Galera, Rosa Alvarez
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18_Supplement): PO-031.
https://doi.org/10.1158/1557-3265.COVID-19-PO-031
Published: 15 September 2020
View articletitled, Abstract PO-031: Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid
Journal Articles

Abstract PO-036: Safety outcomes of resuming anticancer treatment in patients with lung cancer affected by COVID-19 illness

Free
Antonio Calles, Mar Galera, Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, Javier Soto, Victoria Tirado, Rosa Alvarez
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18_Supplement): PO-036.
https://doi.org/10.1158/1557-3265.COVID-19-PO-036
Published: 15 September 2020
View articletitled, Abstract PO-036: Safety outcomes of resuming anticancer treatment in patients with lung cancer affected by COVID-19 illness
Journal Articles

For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity

Free
Ivan Marquez-Rodas, María Angela Aznar, Antonio Calles, Ignacio Melero
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1127–1129.
https://doi.org/10.1158/1078-0432.CCR-18-2690
Published: 15 February 2019
View articletitled, For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity
Open the PDF for For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity in another window
Journal Articles

A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

Free
Florence Atrafi, Harry J.M. Groen, Lauren A. Byers, Elena Garralda, Martijn P. Lolkema, Randeep S. Sangha, Santiago Viteri, Young Kwang Chae, D. Ross Camidge, Nashat Y. Gabrail, Beibei Hu, Tian Tian, Silpa Nuthalapati, Elizabeth Hoening, Lei He, Philip Komarnitsky, Antonio Calles
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (2): 496–505.
https://doi.org/10.1158/1078-0432.CCR-18-2014
Published: 15 January 2019
View articletitled, A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors
Open the PDF for A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study

Free
Glenn J. Hanna, Naifa L. Busaidy, Nicole G. Chau, Lori J. Wirth, Justine A. Barletta, Antonio Calles, Robert I. Haddad, Stefan Kraft, Maria E. Cabanillas, Guilherme Rabinowits, Anne O'Neill, Sewanti A. Limaye, Erik K. Alexander, Francis D. Moore, Jr, Krystof Misiwkeiwicz, Tom Thomas, Matthew Nehs, Ellen Marqusee, Stephanie L. Lee, Pasi A. Jänne, Jochen H. Lorch
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (7): 1546–1553.
https://doi.org/10.1158/1078-0432.CCR-17-2297
Published: 02 April 2018
View articletitled, Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
Open the PDF for Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study in another window
Includes: Supplementary data
Journal Articles

Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

Free
Didier Meulendijks, Wolfgang Jacob, Emile E. Voest, Morten Mau-Sorensen, Maria Martinez-Garcia, Alvaro Taus, Tania Fleitas, Andres Cervantes, Martijn P. Lolkema, Marlies H.G. Langenberg, Maja J. De Jonge, Stefan Sleijfer, Ji-Youn Han, Antonio Calles, Enriqueta Felip, Sang-We Kim, Jan H.M. Schellens, Sabine Wilson, Marlene Thomas, Maurizio Ceppi, Georgina Meneses-Lorente, Ian James, Suzana Vega-Harring, Rajiv Dua, Maitram Nguyen, Lori Steiner, Celine Adessi, Francesca Michielin, Birgit Bossenmaier, Martin Weisser, Ulrik N. Lassen
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (18): 5406–5415.
https://doi.org/10.1158/1078-0432.CCR-17-0812
Published: 14 September 2017
View articletitled, Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity
Open the PDF for Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity in another window
Includes: Supplementary data
Journal Articles

Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer

Free
William J. Gibson, Daniel T. Ruan, Vera A. Paulson, Justine A. Barletta, Glenn J. Hanna, Stefan Kraft, Antonio Calles, Matthew A. Nehs, Francis D. Moore, Jr, Amaro Taylor-Weiner, Jeremiah A. Wala, Travis I. Zack, Thomas C. Lee, Fiona M. Fennessy, Erik K. Alexander, Tom Thomas, Pasi A. Janne, Levi A. Garraway, Scott L. Carter, Rameen Beroukhim, Jochen H. Lorch, Eliezer M. Van Allen
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (9): 2367–2373.
https://doi.org/10.1158/1078-0432.CCR-16-2154-T
Published: 30 April 2017
View articletitled, Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer
Open the PDF for Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer in another window
Includes: Supplementary data
Journal Articles

Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma

Free
Antonio Calles, Lynette M. Sholl, Scott J. Rodig, Ashley K. Pelton, Jason L. Hornick, Mohit Butaney, Christine Lydon, Suzanne E. Dahlberg, Geoffrey R. Oxnard, David M. Jackman, Pasi A. Jänne
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (12): 2851–2860.
https://doi.org/10.1158/1078-0432.CCR-14-3112
Published: 14 June 2015
View articletitled, Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma
Open the PDF for Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors

Free
Dejan Juric, Rodrigo Dienstmann, Andres Cervantes, Manuel Hidalgo, Wells Messersmith, George R. Blumenschein, Jr, Josep Tabernero, Desamparados Roda, Antonio Calles, Antonio Jimeno, Xiaodong Wang, Sandra Sanabria Bohórquez, Cecilia Leddy, Catherine Littman, Amy V. Kapp, David S. Shames, Elicia Penuel, Lukas C. Amler, Andrea Pirzkall, José Baselga
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2462–2470.
https://doi.org/10.1158/1078-0432.CCR-14-2412
Published: 31 May 2015
View articletitled, Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors
Open the PDF for Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors in another window
Journal Articles

Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment

Free
Elena Garralda, Keren Paz, Pedro P. López-Casas, Siân Jones, Amanda Katz, Lisa M. Kann, Fernando López-Rios, Francesca Sarno, Fátima Al-Shahrour, David Vasquez, Elizabeth Bruckheimer, Samuel V. Angiuoli, Antonio Calles, Luis A. Diaz, Victor E. Velculescu, Alfonso Valencia, David Sidransky, Manuel Hidalgo
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2476–2484.
https://doi.org/10.1158/1078-0432.CCR-13-3047
Published: 30 April 2014
View articletitled, Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment
Open the PDF for Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment in another window
Includes: Supplementary data